Snehaa Organics Limited IPO Overview

Snehaa Organics Limited operates in the solvent recovery and recycling sector, providing sustainable solutions to industries that use solvents in their processes. The company collects spent solvents from pharmaceutical and chemical industries and employs distillation and purification technologies to recover them for reuse. Its workforce ensures efficient recovery even from diverse solvent mixtures with high batch variability, maintaining strong quality control standards.

Originally incorporated as Snehaa Pharma Chemicals in 2017, the entity transitioned into Snehaa Organics Pvt Ltd in 2022 and further into a public limited company in January 2025. The manufacturing facility is located at IDA Bollaram, Hyderabad, with a 3,300 sq. ft. plant. The company also trades solvents directly, sourcing raw materials and selling them in the open market.

Core Business and Verticals

Snehaa Organics Limited focuses on solvent recovery and recycling by employing modern technology and purification techniques to process diverse solvent mixtures and ensure efficient recovery. In addition to recycling, the company trades solvents directly, carrying out rigorous quality checks before sale to maintain industry standards. It also undertakes job work services for leading clients in the pharmaceutical sector, offering sustainable and cost-effective solutions that reduce environmental impact while ensuring consistent quality

verticals include:

• Collection & Handling – sourcing and handling spent solvents.

• Purification & Recycling – using distillation and purification technologies.

• Quality Assurance – high standards to meet pharma industry compliance.

• Distribution & Sales – returning recovered solvents to clients or selling in markets.

IPO details

Also read : GEM AROMATICS IPO OVERVIEW

Financial overview

The company shows improving EBITDA margin, strong PAT growth, and effective utilization of capital employed.

Revenue from Operations

Revenue increased steadily from ₹20.10 crore in FY23 to ₹26.22 crore in FY25, reflecting consistent business growth.

This steady rise highlights the company’s ability to expand its solvent recovery and trading operations year after year.

EBITDA

EBITDA rose from ₹5.11 crore in FY23 to ₹11.41 crore in FY25, more than doubling in just three years.
The jump in FY25 indicates improved operational efficiency and higher margins.

Profit After Tax (PAT)

PAT grew from ₹3.25 crore in FY23 to ₹7.34 crore in FY25, showcasing strong bottom-line performance.

This growth reflects effective cost control and higher profitability despite being an SME-scale company.

Also read: Amanta healthcare IPO OVERVIEW

Growth trend

Snehaa Organics has shown a clear upward growth trend, with revenue rising steadily and both EBITDA and PAT more than doubling between FY23 and FY25. This demonstrates not only business expansion but also stronger operational efficiency and profitability over time.

Peer Comparison

In the pharmaceutical sector, Snehaa Organics competes with companies offering solvent recovery and recycling. Peers include larger specialty chemical players. However, as an SME, its scale is smaller but focused. The company highlights cost savings, sustainable solutions, and niche purification technologies as its differentiation.

Also read: How RBI’s FREE-AI Will Transform Financial AI

PAT Comparison

Snehaa Organics reported a profit after tax of ₹7.34 crore, which is strong relative to its small base. Vinati Organics, however, delivered a much larger PAT of ₹232.85 crore, driven by scale and diversified product offerings.

Margin Comparison

Snehaa Organics demonstrates superior profitability with an EBITDA margin of 43.52% and PAT margin of 27.98%, showcasing operational efficiency. Vinati Organics, despite scale, reported 16.65% EBITDA margin and 12.26% PAT margin, indicating thinner margins compared to Snehaa.

Also read: Anlon Healthcare IPO – Complete Analysis

Risks

• High Batch Variability – diverse solvent mixtures may impact consistent recovery.

• Dependence on Pharma Sector – any slowdown could reduce demand.

• Regulatory Risks – GST, environmental clearances, and compliance issues.

• Working Capital Requirements – heavy reliance on funding for raw materials and expansion.

• Competition – from both organized and unorganized solvent recovery players.

Strengths

• Efficient Recovery Processes using modern technology.

• Strong EBITDA Margin and PAT growth.

• Experienced Promoters: Led by Nandigala Venkata Sai Harish and Nandigala Venkata Sai Kiran.

• Sustainable Solutions reducing environmental impact.

• Diverse Client Base including pharmaceutical companies.

• Market Expansion Potential on NSE SME listing.

Conclusion

The Snehaa Organics IPO presents an opportunity for individual investors and retail investors seeking exposure to the pharmaceutical support services and sustainable solvent recovery industry. With a fresh issue of ₹32.68 crore, strong financial performance, and growing EBITDA margin, the company is positioned well. However, risks such as regulatory compliance, dependence on the pharma sector, and working capital needs must be considered.
For those assessing quality in SME IPOs, Snehaa Organics offers a mix of cost savings, sustainable solutions, and growth potential, making it a notable option in the NSE Emerge IPO segment.

Disclaimer: The information provided in our blogs is for informational purposes only and should not be construed as financial, investment, or trading advice. Trading and investing in the securities market carries risk. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results. Copyrighted and original content for your trading and investing needs.

© 2025 — Tradejini. All Rights Reserved.